NATALIA
CARRILLO LOPEZ
Investigador/a
Hospital Universitario de Salamanca
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (2)
2016
-
Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease
Kidney International, Vol. 90, Núm. 1, pp. 77-89
2010
-
Differential effects of 17β-estradiol and raloxifene on bone and lipid metabolism in rats with chronic kidney disease and estrogen insufficiency
Menopause, Vol. 17, Núm. 4, pp. 766-771